Impact of ketamine infusions on healthcare utilization and chronic pain: a comparative effectiveness study with insights from real-world data
- 3 March 2026
- journal article
- Published by BMJ in Regional Anesthesia & Pain Medicine
Abstract
Background Previous studies provide conflicting evidence for ketamine’s effectiveness in treating chronic pain, in the context of limited real-world evidence to augment clinical trial findings. We conducted a comparative effectiveness study with real-world data to assess the impact of ketamine infusions on pain-related healthcare utilization, to bridge the gap between clinical trials and real-life care. Methods We identified 118 subjects who received intravenous (IV) ketamine infusions for chronic pain between 2018 and 2022. Using the University of Pittsburgh’s patient outcomes repository for treatment registry, we created a propensity score-matched control cohort of 118 subjects. Real-world data from the University of Pittsburgh Medical Center healthcare network was analyzed to compare unexpected pain-related healthcare utilization, including emergency room visits, urgent care visits, and hospital admissions. Utilization was assessed 6 months before and after ketamine infusion and compared with the matched control cohort. Results The ketamine cohort demonstrated a decrease in unexpected healthcare utilization 6 months after treatment compared with 6 months prior, while the control cohort showed an increase during the same period. Ketamine treatment was associated with a 45% reduction in pain-related visits compared with the control cohort (pConclusions IV ketamine was more effective than conventional therapy in reducing unexpected pain-related healthcare utilization for over 6 months in patients with chronic pain. Our study highlights the value of using real-world data and comparative effectiveness research to supplement clinical trials and enhance our understanding of the possible effects of outpatient ketamine infusion therapy.Keywords
Funding Information
- Center for Innovation in Pain Care, Dept. of Anesthesiology, University of Pittsburgh (Clinical & Translational Science Institute ID 2590)
This publication has 27 references indexed in Scilit:
- Ketamine for Chronic Pain and Mental Health: Regulations, Legalities, and the Growth of Infusion ClinicsCurrent Pain and Headache Reports, 2023
- Pragmatic Comparative Effectiveness Trials and Learning Health Systems in Pain MedicineAnesthesiology Clinics, 2023
- Ketamine in chronic pain: A Delphi surveyEuropean journal of pain, 2022
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood DisordersJAMA Psychiatry, 2017
- Fat Grafting with Tissue Liquefaction Technology as an Adjunct to Breast ReconstructionAesthetic Plastic Surgery, 2016
- Physical and Psychological Correlates of Fatigue and Physical Function: A Collaborative Health Outcomes Information Registry (CHOIR) StudyThe Journal of Pain, 2015
- Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled studyPain, 2009
- Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1Pain, 2009
- Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global itemsQuality of Life Research, 2009
- A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: results of a double blind randomised controlled trialPain, 2002